Exero Medical Ltd.

www.exeromedical.com

Formerly CanaryCheck

High-Tech Company

Graduated from: MedX

TECH VERTICALS

Diagnostics, Healthtech, Life Sciences, Medical Devices, MedTech, Sensors

General Data

Sector	Medical Devices
Company Stage:	R&D
Established	2018
Number of Employees	15
Reg. Number:	abCDe

DESCRIPTION

Exero Medical is a developer of a biodegradable wireless sensor, designed for early detection of anastomotic leaks following gastrointestinal surgery. The company's device provides patient recovery, the generation of new real-time data and shorter hospitalization, enabling medical professional to monitor the condition of the anastomosis area and take preventive actions before the patient's condition deteriorates.

TECHNOLOGY

Exero Medical's mission is to empower health care providers with high-quality, actionable post-operative tissue healing data that can save lives, improve prognosis and reduce cost of care.

Products and Phases

Product	Phase
Exero Medical biodegradable wireless sensor	Phase I
An implantable biodegradable wireless sensor, designed to continuously monitor the GI tract near the surgical site, alerting physicians to potential anastomotic leakage post-operation. Driven by an adaptive machine-learning engine, this sensor are intended to detect patient deterioration during the recovery period and also enable early patient discharge by identifying healthy tissue healing.

	TARGET MARKETS
	Hospitals.

	BUSINESS MODEL
	B2B

COMPETITORS

FluidAI Medical

CONTACT INFO

Expand / Collapse All

Main Address: Or Yehuda, Israel

Address	8 Ariel Sharon St.
City	Or Yehuda
Country	Israel
Zip	6037606

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Dr. Erez Shor	CEO	VisionMap (VP, Products)
Mr. Noam Taichler	CFO	HydroSpin (CFO)
Ms. Ilana Fishman	VP, Regulatory & Clinical Operations	RegenoGel (CRO & Project Management)
Dr. Gilad Lerman	VP, R&D
Ms. Eileen Ke	VP, Business Development
Dr. Amir Kreitzer	Medical Director & Co-Founder
Dr. Matan Ben-David	Co-Founder	Gema Medical (Co-Founder)

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Chairman	Managing Partner & Co-Founder, Edge Medical Ventures
abC Defghij	Board Member	CEO & Co-Founder, Exero Medical
abC Defghij	Board Member	Co-Founder, Exero Medical
abC Defghij	Board Member	Managing Partner & Co-Founder, Longevity Venture Partners (LVP)
abC Defghij	Observer	Former VP Business Development, Medical Devices & Digital Health, Mor Research Applications
abC Defghij	Observer	Co-Founder Exero
abC Defghij	Observer	Partner, Tech Council Ventures

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Seed - Extended

Feb. 13, 2025

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Investment Company	abCDe

Seed - Extended

Jun. 01, 2024

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Investment Company	abCDe

Seed - Extended

Dec. 15, 2021

Seed

abCDe

SAFE deal.

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Services	abCDe

Seed

Sep. 01, 2018

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Technology Transfer Company	abCDe
abC Defghij	Government Agency	abCDe	R&D Grant
abC Defghij	Incubator	abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Feb. 13, 2025

Seed

abCDe

Non-dilutive

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Other	abCDe

R&D Grant

Jun. 01, 2024

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Fund	abCDe

R&D Grant

Jun. 01, 2021

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Government Agency	abCDe

Last Updated:	abCDe
IVC Number:	abCDe